128 related articles for article (PubMed ID: 9876816)
1. Topotecan: a new topoisomerase I inhibiting antineoplastic agent.
Cersosimo RJ
Ann Pharmacother; 1998 Dec; 32(12):1334-43. PubMed ID: 9876816
[TBL] [Abstract][Full Text] [Related]
2. Clinical status and optimal use of topotecan.
Takimoto CH; Arbuck SG
Oncology (Williston Park); 1997 Nov; 11(11):1635-46; discussion 1649-51, 1655-7. PubMed ID: 9394364
[TBL] [Abstract][Full Text] [Related]
3. Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience.
Kollmannsberger C; Mross K; Jakob A; Kanz L; Bokemeyer C
Oncology; 1999; 56(1):1-12. PubMed ID: 9885371
[TBL] [Abstract][Full Text] [Related]
4. New options for the treatment of advanced ovarian cancer.
Dunton CJ
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues.
Arun B; Frenkel EP
Expert Opin Pharmacother; 2001 Mar; 2(3):491-505. PubMed ID: 11336601
[TBL] [Abstract][Full Text] [Related]
7. The development of camptothecin analogs in childhood cancers.
Bomgaars L; Berg SL; Blaney SM
Oncologist; 2001; 6(6):506-16. PubMed ID: 11743213
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetic analysis of topotecan in pediatric cancer patients.
Schaiquevich P; Panetta JC; Iacono LC; Freeman BB; Santana VM; Gajjar A; Stewart CF
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6703-11. PubMed ID: 18006771
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase I inhibitors in the treatment of colorectal cancer.
Rothenberg ML; Blanke CD
Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
[TBL] [Abstract][Full Text] [Related]
10. Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
Saltz L; Janik JE
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-26-S5-30. PubMed ID: 9122740
[TBL] [Abstract][Full Text] [Related]
11. Topotecan in the treatment of gynecologic cancer.
Coleman RL; Miller DS
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-55-S20-63. PubMed ID: 9425962
[TBL] [Abstract][Full Text] [Related]
12. An overview of topoisomerase I-targeting agents.
Arbuck SG; Takimoto CH
Semin Hematol; 1998 Jul; 35(3 Suppl 4):3-12. PubMed ID: 9779876
[TBL] [Abstract][Full Text] [Related]
13. Topotecan in small cell lung cancer.
Schiller JH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
[TBL] [Abstract][Full Text] [Related]
14. A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients.
Homesley HD; Hall DJ; Martin DA; Lewandowski GS; Vaccarello L; Nahhas WA; Suggs CL; Penley RG
Gynecol Oncol; 2001 Nov; 83(2):394-9. PubMed ID: 11606103
[TBL] [Abstract][Full Text] [Related]
15. Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain.
Ojeda B; de Sande LM; Casado A; Merino P; Casado MA
Br J Cancer; 2003 Sep; 89(6):1002-7. PubMed ID: 12966416
[TBL] [Abstract][Full Text] [Related]
16. Current role and future aspects of topotecan in relapsed ovarian cancer.
Sehouli J; Oskay-Ozcelik G
Curr Med Res Opin; 2009 Mar; 25(3):639-51. PubMed ID: 19232038
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan: a new antineoplastic agent for the management of colorectal cancer.
Cersosimo RJ
Ann Pharmacother; 1998 Dec; 32(12):1324-33. PubMed ID: 9876815
[TBL] [Abstract][Full Text] [Related]
18. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
[TBL] [Abstract][Full Text] [Related]
19. Topotecan in the treatment of non-small cell lung cancer.
Perez-Soler R
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-34-S20-41. PubMed ID: 9425959
[TBL] [Abstract][Full Text] [Related]
20. Review of phase I clinical studies with topotecan.
Rowinsky EK; Verweij J
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-3-S20-10. PubMed ID: 9425956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
